An Investigation Into the Detection and Mitigation of Denial of Service (DOS) Attacks
Critical Information Infrastructure Protection
Price includes NZ wide delivery!
|Format: ||Hardcover, 348 pages, 2011 Edition|
|Published In: ||India, 01 October 2011|
Around the globe, nations face the problem of protecting their Critical Information Infrastructure, normally referred to as Cyber Space. In this monograph, we capture FIVE different aspects of the problem; High speed packet capture, Protection through authentication, Technology Transition, Test Bed Simulation, and Policy and Legal Environment. The monograph is the outcome of over three years of cooperation between India and Australia.
Table of Contents
PREFACE.-1. Introduction.-2. Diversity oriented fluorescence library approach for stem cell probe development.-3. Isolation of mesenchymal stem cells from umbilical cord (method).-4. Mesenchymal stem cell isolation and expansion methodology.-5. Hair follicle stem cells.- 6. Rat embryonic cortical neural stem cells: role of hypoxia on cell proliferation and differentiation.-7. Human cord blood-derived hematopoietic stem and progenitor cells: from biology to medicine.-8. Proteomic characterization of mesenchymal stem cell-like populations derived from various tissue types.-9. The roles of nanog during early embryonic development and primordial germ cell migration.-10. Human embryonic stem cells in serum-free media: growth and metabolism. I. MOLECULAR GENETICS.-11. Evolutionary dynamics of mutations in hematopoietic stem cells and beyond.-12. Isolated corneal epithelial stem cells derived from limbal biopsies: use of lectin as a marker for identifying transient amplifying cells.-13. Stem cell distribution and mgmt expression in glioblastoma: role of intratumoral hypoxic gradient.- 14. Initiation of human tumourigenesis: upregulation of foxm1 transcription factor. II THERAPY.-15. Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy.-16.Ccell-based regenerative therapies: role of major histocompatibility complex-1 antigen.-17. Mesenchymal stem cells for cellular therapies.-18. Radiation burns and mesenchymal stem cell therapy.-19. Mesenchymal stem cells: role of mechanical strain in promoting apoptosis and differentiation.-20. Human mesenchymal stem cells: melatonin as a potential anti-osteoporosis drug.-21. Applications of human - induced pluripotent stem cell derived hepatocytes.-22. Stem cells and gastric carcinogenesis: from mouse to human.-23. Gain and loss of cancer stem cells: effect on metastatic efficiency and treatment response.-24. Treatment of ischemia/reperfusion injury of the kidney with mesenchymal stromal cells.-25. Mesenchymal stem cells: role for delivering nanoparticles to brain tumors.-26. Human induced pluripotent stem cells: role in patient specific drug discovery.-27. Biomedical applications of induced pluripotent stem cells.-28. Duchenne muscular dystrophy: isolation of cd133-expressing myogenic progenitors from blood and muscle of dmd patients. III TRANSPLANTATION.-29. Human fetal mesenchymal stem cells for prenatal and postnatal transplantation.-30. Protection of mice from stroke using hematopoietic stem cell transplantation.-31. Neonatel hypoxic-ischemic encephalopathy: neural stem/progenitor cell transplantation. IV TISSUE REGENERATION.-32. Mesenchymal stem cell-dependent formation and repair of tendon-done insertions.-33 . Cartilage injuries: role of implantation of human stem/progenitor cells.-34. Bone marrow-derived very small embryonic-like cells: I -cell regeneration in pancreatic tissue.- 35. Engineering stem cell niche: regulation of cellular morphology and function.- V APOPTOSIS.-36. Embryonic stem cells: the role of nitric oxide in regulating cell differentiation, self-renewal, and apoptpsis.- 37. Induction of apoptosis in human keratinocyte stem cells: the role of hydrogen sulfide. Index
23.11 x 15.49 x 2.29 centimetres (0.64 kg)|
15+ years |